Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$138.42 - $180.31 $83,744 - $109,087
605 New
605 $85,000
Q3 2021

Nov 12, 2021

SELL
$194.77 - $324.21 $2.67 Million - $4.44 Million
-13,687 Reduced 95.77%
605 $174,000
Q2 2021

Aug 13, 2021

SELL
$165.87 - $220.95 $410,362 - $546,630
-2,474 Reduced 14.76%
14,292 $2.85 Million
Q1 2021

May 14, 2021

SELL
$180.37 - $226.26 $1.9 Million - $2.39 Million
-10,550 Reduced 38.62%
16,766 $3.26 Million
Q4 2020

Feb 12, 2021

SELL
$148.08 - $206.57 $98,473 - $137,369
-665 Reduced 2.38%
27,316 $5.23 Million
Q3 2020

Nov 13, 2020

SELL
$122.51 - $158.27 $259,843 - $335,690
-2,121 Reduced 7.05%
27,981 $4.13 Million
Q2 2020

Aug 14, 2020

SELL
$94.33 - $140.48 $1.34 Million - $1.99 Million
-14,164 Reduced 32.0%
30,102 $3.72 Million
Q1 2020

May 14, 2020

SELL
$84.96 - $109.14 $1.22 Million - $1.56 Million
-14,328 Reduced 24.45%
44,266 $4.27 Million
Q4 2019

Feb 14, 2020

SELL
$73.84 - $93.08 $66,899 - $84,330
-906 Reduced 1.52%
58,594 $5.42 Million
Q3 2019

Nov 14, 2019

SELL
$76.65 - $95.51 $85,388 - $106,398
-1,114 Reduced 1.84%
59,500 $4.56 Million
Q2 2019

Aug 14, 2019

BUY
$54.2 - $85.95 $3.29 Million - $5.21 Million
60,614 New
60,614 $5.21 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $9.03B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Next Century Growth Investors LLC Portfolio

Follow Next Century Growth Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Next Century Growth Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Next Century Growth Investors LLC with notifications on news.